⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 11, 2010OncotargetOpen Access

Beta-adrenergic signaling, a novel target for cancer therapy?

View Full Paper

Ask AI

Bookmark

Share

Abstract

Received: November 9, 2010 , Accepted: November 10, 2010 , Published: November 11, 2010 //

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hildegard M. Schuller (2010) studied this question.

synapsesocial.com/papers/6a7b2f5f02ab7a73dd033ca8 https://doi.org/10.18632/oncotarget.182

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1NNK activates ERK1/2 and CREB/ATF‐1 <i>via</i> β‐1‐AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cellsOriginal Research · 2006 · 88 citations
2beta-Adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomasOriginal Research · 2001 · 137 citations
3Prevention of pancreatic cancer by the beta-blocker propranololOriginal Research · 2009 · 121 citations
4Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell linesOriginal Research · 2004 · 44 citations